|
| Exchange Received Time 28/04/2017 19:50:14 Exchange Disseminated Time 28/04/2017 19:50:17 Time Taken 00:00:03 | | The Company is seeking approval of the shareholders for the 'Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited (Transferee Company) and Neuland Health Sciences Private Limited (First Transferor Company) and Neuland Pharma Research Private Limited (Second Transferor Company) and their respective Shareholders and Creditors' ('Scheme')' under Sections 230 to 232 read with Section 66 and other applicable provisions, if any, of the Companies Act, 2013 by way of Tribunal Convened Meeting / E-voting. A copy of the Notice of the Tribunal Convened Meeting dispatched to the Shareholders on even date is enclosed. |
|
|